Springfield committee moves to pursue 21+ age restriction on kratom amid calls to ban concentrated 7‑OH products

A Springfield City subcommittee on health and human services on Tuesday agreed to pursue a local 21+ age restriction for kratom sales as members and health experts urged action to remove concentrated 7‑hydroxy (7‑OH) kratom products from convenience stores.

The committee convened a panel that included Allison Smith, director of government affairs for the Global Kratom Coalition; Dr. Sharron Colgram of the Public Health Council; Dr. Ari Kriegsman, medical director of BHN’s Springfield opioid treatment program; and retail representatives. Smith said her group supports regulated adult access to natural kratom leaf while "prohibit[ing] concentrated synthetic 7‑OH," calling the concentrated product “gas station heroin” and saying it is "13 times more potent than morphine." Dr. Kriegsman described kratom and some derivatives as opioids at higher doses and cautioned that concentrated synthetics appear more potent and riskier than the natural leaf.

The panel framed several practical issues for local lawmakers. Public-health members and clinicians emphasized uncertainty in long‑term clinical data for natural kratom and the need for warning labels and public‑education measures. Dr. Colgram said the Public Health Council focused on clearly defining "natural kratom versus 7‑OH," assessing toxicity, and protecting vulnerable populations who rely on kratom for pain management or to avoid illicit opioids. Dr. White, another public‑health speaker, recommended banning some concentrated products while regulating others and said the ordinance before the city had many of the right elements.

Retailers and industry representatives urged using objective thresholds and vendor lists to distinguish safe products from high‑risk synthetics. Joe Van Ward, a contractor working with more than 200 stores, described large concentration differences between whole‑leaf products and synthetics and suggested adopting an enforceable threshold and third‑party testing for vendors. The panel noted existing federal and state activity — speakers referenced prior HHS/FDA/DEA attention and pending state bills — but said action at those levels is slow.

Faced with enforcement concerns about local testing capacity, the committee coalesced around a near‑term step: drafting local language to require a 21+ age gate for kratom products, tighten labeling and packaging rules to prevent child‑appealing designs, and place compliance obligations on retailers (for example, requiring third‑party testing and clear milligram labeling). "21 age gating is a fantastic starting point," Allison Smith said, and multiple committee members agreed it could be adopted by ordinance while the city pursues coordination with the state legislature and the law department.

Public commenters included longtime users who said natural kratom helped them manage pain and others who described encountering 7‑OH in stores. Judy Torres, a Springfield resident and self‑described long‑term kratom consumer, urged protection of access to plant‑form products for people who rely on them for chronic pain. Steven Howard and other residents urged strong local rules to protect children.

The meeting ended with the chair directing staff to work with the law department and the health subcommittee on draft language, to follow up with the local delegation about state bills, and to return with a plan that focuses first on a 21+ restriction while addressing enforcement and labeling requirements.

Next steps: the committee asked the law department to draft 21+ language and explore enforcement mechanisms and asked staff to report back with proposed ordinance text and possible model language from other jurisdictions.